{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:02:15Z","timestamp":1781326935849,"version":"3.54.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"DOI":"10.7759\/cureus.91223","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:37:59Z","timestamp":1756460279000},"source":"Crossref","is-referenced-by-count":2,"title":["Sequential Development of Chronic Lymphocytic Leukemia (CLL) in a Chronic Myeloid Leukemia (CML) Patient Treated With Nilotinib: A Case Report"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Elazab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged","family":"Saafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen","family":"Elbayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia","volume":"38","author":"Bhagavathi S","year":"2008","unstructured":"Bhagavathi S, Borromeo V, Desai H, Crisan D. Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia. Ann Clin Lab Sci. 2008, 38:405-9.","journal-title":"Ann Clin Lab Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.6767","article-title":"Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?","volume":"30","author":"D'Arena G","year":"2012","unstructured":"D'Arena G, Gemei M, Luciano L, et al.. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?. J Clin Oncol. 2012, 30:e327-30. 10.1200\/JCO.2012.42.6767","journal-title":"J Clin Oncol"},{"key":"ref3","article-title":"The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review","volume":"56","author":"Cri\u015fan AM","year":"2015","unstructured":"Cri\u015fan AM, B\u0103deli\u0162\u0103 SN, Jardan C, et al.. The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review. Rom J Morphol Embryol. 2015, 56:1145-51.","journal-title":"Rom J Morphol Embryol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.125369","article-title":"Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: report of an unusual case","volume":"56","author":"Rahman K","year":"2013","unstructured":"Rahman K, George S, Mangal S, Mehta A. Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: report of an unusual case. Indian J Pathol Microbiol. 2013, 56:453-6. 10.4103\/0377-4929.125369","journal-title":"Indian J Pathol Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12890\/2024_004297","article-title":"A rare case of an elderly male with progression to chronic myeloid leukaemia secondary to chronic lymphocytic leukaemia","volume":"11","author":"Saowapa S","year":"2024","unstructured":"Saowapa S, Pangkanon W, Adu Y, et al.. A rare case of an elderly male with progression to chronic myeloid leukaemia secondary to chronic lymphocytic leukaemia. Eur J Case Rep Intern Med. 2024, 11:004297. 10.12890\/2024_004297","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/1813512","article-title":"High-risk chronic lymphocytic leukemia complicating the course of imatinib-treated chronic myeloid leukemia: successful disease management with dual tyrosine kinase inhibition","volume":"2024","author":"James D","year":"2024","unstructured":"James D, Green S, Molica S, Allsup D. High-risk chronic lymphocytic leukemia complicating the course of imatinib-treated chronic myeloid leukemia: successful disease management with dual tyrosine kinase inhibition. Case Rep Hematol. 2024, 2024:1813512. 10.1155\/2024\/1813512","journal-title":"Case Rep Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus A","year":"2017","unstructured":"Hochhaus A, Larson RA, Guilhot F, et al.. Long-term outcomes of imatinib treatment for chronic myeloid leukemia. N Engl J Med. 2017, 376:917-27. 10.1056\/NEJMoa1609324","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.20","article-title":"Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV","volume":"30","author":"Miranda MB","year":"2016","unstructured":"Miranda MB, Lauseker M, Kraus MP, et al.. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia. 2016, 30:1255-62. 10.1038\/leu.2016.20","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst B","year":"2021","unstructured":"Eichhorst B, Robak T, Montserrat E, et al.. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021, 32:23-33. 10.1016\/j.annonc.2020.09.019","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.974","article-title":"Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia","volume":"5","author":"Shea LK","year":"2017","unstructured":"Shea LK, Mikhail FM, Forero-Torres A, Davis RS. Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia. Clin Case Rep. 2017, 5:899-901. 10.1002\/ccr3.974","journal-title":"Clin Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402033-sequential-development-of-chronic-lymphocytic-leukemia-cll-in-a-chronic-myeloid-leukemia-cml-patient-treated-with-nilotinib-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:38:00Z","timestamp":1756460280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402033-sequential-development-of-chronic-lymphocytic-leukemia-cll-in-a-chronic-myeloid-leukemia-cml-patient-treated-with-nilotinib-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.91223","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}